Source:http://linkedlifedata.com/resource/pubmed/id/17512555
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-6-18
|
pubmed:abstractText |
We investigated the effects of BMP-2 and dexamethasone (Dex) on follistatin (FS) and activin A expressions in a mesenchymal progenitor cell line, ROB-C26 (C26). C26 cells stimulated to differentiate into osteoblastic cells by blocking myogenic differentiation after BMP-2 treatment and into adipocytes with Dex treatment. Alkaline phosphatase (ALP) mRNA expression and its activity in the confluent C26 cells were dose- and time-dependently stimulated by BMP-2, but inhibited by Dex. The stimulatory effect on FS and activin A mRNA expressions by BMP-2 and Dex were dose-dependent. Cycloheximide pre-treatment indicated that FS and activin A expressions appear to be the direct target of BMP-2 and Dex signaling. BMP-2 time-dependently increased FS and activin A levels. Dex also increased FS level, but induced a time-dependent biphasic effect on activin A level, a decrease (2-6 h) followed by an increase (12-72 h). The data of the ratio of activin A concentration in the culture media to that of FS (activin A:FS ratio) measured by ELISA showed that BMP-2-induced osteoblastic differentiation involved an activin-dominant microenvironment, whereas Dex-induced adipocyte differentiation involved a FS-dominant microenvironment. Excess FS suppressed the stimulatory ALP activity of BMP-2, whereas activin A prevented not only Dex-induced inhibitory ALP activity, but also adipogenesis via suppression of the adipocyte transcriptional factor cascade. These results indicate that BMP-2-induced activin-dominant microenvironment may be critical for osteoblastic differentiation by restricting the antagonistic effects of FS on BMP activity, while Dex-induced FS-dominant microenvironment may be critical for adipocyte differentiation by restricting the inhibitory action of activin A on adipocyte differentiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Activins,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Follistatin,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/activin A
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8-18
|
pubmed:meshHeading |
pubmed-meshheading:17512555-Activins,
pubmed-meshheading:17512555-Adipocytes,
pubmed-meshheading:17512555-Animals,
pubmed-meshheading:17512555-Bone Morphogenetic Proteins,
pubmed-meshheading:17512555-Cell Differentiation,
pubmed-meshheading:17512555-Cell Line,
pubmed-meshheading:17512555-Dexamethasone,
pubmed-meshheading:17512555-Dose-Response Relationship, Drug,
pubmed-meshheading:17512555-Extracellular Space,
pubmed-meshheading:17512555-Follistatin,
pubmed-meshheading:17512555-Mesenchymal Stem Cells,
pubmed-meshheading:17512555-Osteoblasts,
pubmed-meshheading:17512555-RNA, Messenger,
pubmed-meshheading:17512555-Rats,
pubmed-meshheading:17512555-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:17512555-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Changes in extracellular activin A:follistatin ratio during differentiation of a mesenchymal progenitor cell line, ROB-C26 into osteoblasts and adipocytes.
|
pubmed:affiliation |
Department of Oral and Maxillofacial Surgery Nihon University School of Dentistry, Tokyo 101-8310, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|